Qiu-Wan Wu

First Affiliated Hospital of Xiamen University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index580citations24works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(8), Autophagy in Disease and Therapy(7), MicroRNA in disease regulation(6), Lymphatic System and Diseases(5), RNA modifications and cancer(5)

Publications24 total

Factors associated with glycemic control in patients with T2DM: evidence from a cross-sectional study in China
BMC Endocrine Disorders·2024· 2 citedOpen Access
Factors associated with glycemic control in patients with T2DM: evidence from a cross-sectional study in China
Research Square (Research Square)·2024Open Access
Correction: Current perspectives on cell-assisted lipotransfer for breast cancer patients after radiotherapy
World Journal of Surgical Oncology·2023· 1 citedOpen Access
Current perspectives on cell-assisted lipotransfer for breast cancer patients after radiotherapy
World Journal of Surgical Oncology·2023· 9 citedOpen Access
Table S1 from Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
2023Open Access
Supplementary methods from Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
2023Open Access
Supplementary Figures from Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
2023Open Access
Table S1 from Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
2023Open Access
Supplementary Figures from Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
2023Open Access
Data from Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
2023Open Access
Supplementary methods from Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
2023Open Access
Data from Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
2023Open Access
Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1
Journal of Cancer·2021· 9 citedOpen Access
Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis
Cancer Letters·2018· 31 cited
Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription
British Journal of Cancer·2018· 35 citedOpen Access
Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
Cancer Research·2018· 34 cited
OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis
Oncotarget·2017· 39 citedOpen Access
SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition
Oncology Reports·2017· 48 citedOpen Access
MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN)
Cell & Bioscience·2014· 90 citedOpen Access
Expression and Clinical Significance of Matrix Metalloproteinase-9 in Lymphatic Invasiveness and Metastasis of Breast Cancer
PLoS ONE·2014· 42 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Peipei Hou(9), Qi-Tao Chen(9), Xiaoyu Sun(9), Pengbo Yang(9), Ying-Ping Li(9), Luming Yao(9), Xin‐Dong Jiang(9), Kun‐Yi Chien(9), Allison J. Cowin(9), Hang‐zi Chen(9), Zhiming Zhang(8), Qiao Wu(8), Jianping He(7), Weijia Wang(5), Xiaotong Li(5), Zhiming Zhang(5), Zhiming Zhang(4), Donghan Chen(4), Weijia Wang(4), Xiaotong Li(4)